Universal Biosensors surges 60% on FDA approval for Class II device
Universal Biosensors shares surged 60% following the attainment of US Food and Drug Administration and Clinical Laboratory Improvement Amendments Waiver approvals.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
ASP | Ann: ASP NTA 18-03-2024 $1.38270 | 08:03 | 0 | 17 | |||
|
|||||||
ASP | Ann: ASP NTA 15-03-2024 $1.38849 | 18/03/24 | 0 | 23 | |||
|
|||||||
ASP | Ann: ASP NTA 14-03-2024 $1.37259 | 15/03/24 | 0 | 37 | |||
|
|||||||
ASP | Ann: ASP NTA 13-03-2024 $1.36752 | 14/03/24 | 0 | 34 | |||
|
|||||||
ASP | Ann: ASP NTA 12-03-2024 $1.36157 | 13/03/24 | 0 | 31 | |||
|
|||||||
ASP | Ann: ASP NTA 11-03-2024 $1.36112 | 12/03/24 | 0 | 21 | |||
|
|||||||
ASP | Ann: ASP NTA 08-03-2024 $1.37037 | 11/03/24 | 0 | 34 | |||
|
|||||||
ASP | Ann: ASP NTA 07-03-2024 $1.35130 | 08/03/24 | 0 | 41 | |||
|
See All Discussions